Intelligent Clinical AI: How ONYX Healthcare Exemplifies
Taiwan’s Smart Healthcare Pavilion

Guided by its vision to "bring medical AI innovation with care," ONYX Healthcare Inc. develops medical-grade edge computing platforms that enable secure on-site AI inference and DICOM workflow integration. Built for 24/7 reliability, fast system integration, and scalable clinical deployment, ONYX's solutions play a critical role in powering the Internet of Medical Things (IoMT) and supporting secure healthcare operations. To transform cutting-edge computing capabilities into clinical-ready solutions, ONYX has forged strategic partnerships with three global semiconductor leaders: Intel, NVIDIA, and Qualcomm.

As one of the first embedded-computing manufacturers worldwide to build products based on the NVIDIA Clara Holoscan MGX™ reference design, ONYX leverages NVIDIA's medical-grade architecture, accelerated computing, and 10-year software support (including IEC 62304 documentation and IEC 60601 attestations) to deploy real-time AI applications at the edge. Furthermore, ONYX is among the first to integrate Intel® Core™ Ultra processors into medical AI systems—such as its VM Series and mobile nursing computers—for diagnostic support and imaging workflows. ONYX also achieved a world-first milestone by mass-producing a 10.1-inch medical tablet powered by Qualcomm® Snapdragon™ and Windows, delivering 5G connectivity, low-power AI, and medical-grade durability for mobile nursing care.

Smart Healthcare focuses on advancing precision medicine and smart care across precision diagnosis, smart monitoring, rehabilitation training, clinical decision support, and long-term care. Demonstrating how healthcare services extend from hospitals into homes and long-term care settings, the pavilion shows how Taiwan creates a medical ecosystem that is timely, precise, and human-centered.

The pavilion presents Taiwan’s integrated capabilities across AI-assisted diagnosis, clinical data analytics, medical image processing, wearable monitoring, contactless safety care, chronic disease management, smart rehabilitation, and assistive technologies. AI and medical-grade edge computing allow healthcare institutions to introduce AI applications in secure environments, improving interpretation efficiency, early risk detection, and clinical workloads. Remote monitoring, smart wearables, and digital care platforms enable continuous patient tracking and proactive interventions, providing precise and sustainable support for aging populations, mobility challenges, and rehabilitation needs to build a resilient healthcare future.

AIxMed specializes in AI digital pathology with multi-national clinical data integration. Adhering to TPS (The Paris System) 2.0 standards and global medical device software regulations, its first-in-class AIxURO software is a market pioneer in urine bladder cancer cell recognition, eliminating subjective diagnostic variance. Validated through clinical collaborations with top U.S. medical centers (including Johns Hopkins, Ohio State, UPMC, and MGH/Harvard), AIxURO boosts diagnostic sensitivity up to 93% and slashes review turnaround time by 65% (reducing average review time from 103 seconds to 36 seconds). It was awarded the ASC 2025 "Innovations in Cytopathology Practice Award."

FREE Bionics delivers AI-driven exoskeleton technology for precision rehabilitation, personal assistance, and long-term care re-enablement. Utilizing AI algorithms rather than physical sensors to assess user movement and capabilities, its platform provides accessible data analytics adopted across 100 healthcare institutions in 22 countries throughout Asia and Europe (accumulating 40,000+ training sessions) and integrated by a World's Top 10 medical center in Singapore. Invested by Taiwan's National Sovereign Fund, FREE Bionics has won 1st Prize at Europe's Life Science Baltics, the US Health Longevity Award, and the Taipei Biotech Award.

Huijia Health provides the patented nFOPT® AI Smart Sensor, utilizing non-invasive fiber optic sensing free from electromagnetic interference with 100x higher signal resolution. Combined with AI algorithms, this single-sensor solution enables continuous, 24/7 non-contact monitoring of physiological data (heart rate and respiration) without requiring wearables—reducing labor costs by over 30% across hospitals, senior care, and home settings. Huijia won two Gold Medals at the 2025 APICTA Awards, the DWP 2025 Award, and was selected for GlobalStartupEXPO 2025 at the Osaka-Kansai Expo.

VitalSigns integrates 500Hz/24-bit high-fidelity ECG acquisition, real-time cloud transmission, and AI analytics into its Proactive Cardiac Monitoring and Alert Platform. By extending cardiac tracking beyond brief clinic visits into continuous, real-time monitoring during daily life and sleep, the platform provides automated abnormality alerts for earlier risk detection. It reduces manual review workloads for clinicians and seamlessly aligns with U.S. care models, including remote care, Hospital-at-Home, and post-discharge monitoring.